Williams Jones & Associates’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Williams Jones & Associates's IDXX Position: Q2 2019 in Review
Williams Jones & Associates reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2019, selling an estimated $1.63M and leaving 541,523 shares worth $149M. The position accounts for 3.09% of the portfolio, ranked #3.
Williams Jones & Associates first reported a position in IDXX in Q2 2016 and has held it in 13 quarters since. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.
- Williams Jones & Associates held 541,523 shares of Idexx Laboratories worth $149M as of Q2 2019.
- Williams Jones & Associates sold 6,600 Idexx Laboratories shares in Q2 2019, an estimated $1.63M.
- Idexx Laboratories made up 3.09% of Williams Jones & Associates's portfolio in Q2 2019, its #3 holding.
- Williams Jones & Associates first reported a position in Idexx Laboratories in Q2 2016 and has held it in 13 quarters since.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.
Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.